Dr. Alper

The Founder and Lead Scientist, Dr. Özge Alper, research experience spans 25 years including work in clinical chemistry, cancer biology, cancer diagnosis and treatment. She completed her Ph.D. at Tokyo University, Japan; Clinical Biochemistry Residency at Hacettepe University, Turkey. She became Research Assistant Professor at Georgetown University and senior scientist at Surgical Neurology at National Institute of Neurological Disorders at NIH before she founded Alper Biotech. Most Recently, Dr. Alper established new diagnostic tests for breast cancer and is widely published in the field. Dr. Alper's publications and granted patents are available at pubmed and ADXRX website: adxrx.com

December 2017